Rockwell Medical (RMTI) Operating Leases (2019 - 2026)

Rockwell Medical (RMTI) has reported Operating Leases for 8 consecutive years, with $4.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Leases rose 26.74% year-over-year to $4.4 million; the trailing twelve-month figure through Jun 2026 stood at $4.4 million (up 26.74% YoY), and the FY2025 full-year result was $1.5 million, down 14.42% from the prior year.
• Operating Leases declined to $4.4 million in Q2 2026 per RMTI's latest filing, from $4.8 million in the prior quarter.
• Across five years, Operating Leases topped out at $7.4 million in Q1 2022 and bottomed at $1.4 million in Q4 2023.
• Historically, Operating Leases has averaged $3.8 million across 5 years, with a median of $3.6 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Operating Leases plunged 56.16% in 2022, then jumped 66.27% in 2026.
• Over 5 years, Operating Leases stood at $2.6 million in 2022, then slumped by 44.48% to $1.4 million in 2023, then gained by 18.56% to $1.7 million in 2024, then declined by 14.42% to $1.5 million in 2025, then jumped by 201.86% to $4.4 million in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $4.4 million, $4.8 million, and $1.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.